nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
|
Klar, Richard |
|
|
69 |
1 |
p. 57-67 |
artikel |
2 |
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody
|
Shibaki, Ryota |
|
|
69 |
1 |
p. 15-22 |
artikel |
3 |
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
|
Erin, Nuray |
|
|
69 |
1 |
p. 103-114 |
artikel |
4 |
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers
|
Kikuchi, Tomohiro |
|
|
69 |
1 |
p. 23-32 |
artikel |
5 |
Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer
|
Waidhauser, Johanna |
|
|
69 |
1 |
p. 147-157 |
artikel |
6 |
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
|
Mensali, Nadia |
|
|
69 |
1 |
p. 159-161 |
artikel |
7 |
GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma
|
Rashidi, Aida |
|
|
69 |
1 |
p. 81-94 |
artikel |
8 |
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
|
Yu, Chunyan |
|
|
69 |
1 |
p. 115-126 |
artikel |
9 |
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
|
Yu, Chunyan |
|
|
69 |
1 |
p. 115-126 |
artikel |
10 |
Interleukin-38 in colorectal cancer: a potential role in precision medicine
|
Chen, Feier |
|
|
69 |
1 |
p. 69-79 |
artikel |
11 |
Mechanisms of immune evasion in bladder cancer
|
Crispen, Paul L. |
|
|
69 |
1 |
p. 3-14 |
artikel |
12 |
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
|
Zhang, Rui |
|
|
69 |
1 |
p. 135-145 |
artikel |
13 |
Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells
|
Romero, Yeni |
|
|
69 |
1 |
p. 43-55 |
artikel |
14 |
Solid pavestones are needed to pave a solid way to success
|
Dong, Haidong |
|
|
69 |
1 |
p. 1 |
artikel |
15 |
Tailoring early-phase clinical trial design to address multiple research objectives
|
Wages, Nolan A. |
|
|
69 |
1 |
p. 95-102 |
artikel |
16 |
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
|
Ozaki, Yuki |
|
|
69 |
1 |
p. 127-134 |
artikel |
17 |
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
|
Zong, Liju |
|
|
69 |
1 |
p. 33-42 |
artikel |